Market revenue in 2023 | USD 151.0 million |
Market revenue in 2030 | USD 347.9 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Ph sensor |
Fastest growing segment | PH Sensor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PH Sensor, Oxygen Sensors, Pressure Sensors, Temperature Sensors, Conductivity Sensors, Flow Meter & Sensors, Other Sensors |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corp, Alphabet Inc Class C, Booz Allen Hamilton Holding Corp Class A, Compagnie de Saint-Gobain SA, Parker Hannifin Corp, Dover Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to single-use bioprocessing probes and sensors market will help companies and investors design strategic landscapes.
Ph sensor was the largest segment with a revenue share of 20.13% in 2023. Horizon Databook has segmented the UK single-use bioprocessing probes and sensors market based on ph sensor, oxygen sensors, pressure sensors, temperature sensors, conductivity sensors, flow meter & sensors, other sensors covering the revenue growth of each sub-segment from 2018 to 2030.
The UK holds a notable share of the single-use bioprocessing market in Europe. The regional market’s overall growth trajectory is positive as the government is investing funds to assist local players and create a competitive advantage against international players.
For example, in December 2020 the UK government in response to the global manufacturing crisis during the COVID-19 pandemic funded around USD 270 million via VTF (Vaccine Taskforce). This funding allowed the establishment of the Vaccine Manufacturing and Innovation Centre (VMIC), west of London, to offer single-use bioreactors for vaccine manufacturing.
With the UK being one of the leading European countries for manufacturing advanced therapies, it has resulted in lucrative opportunities for the single-use bioprocessing market in the country. Similarly, in March 2022, the UK government announced a USD 339 million investment to boost life science & healthcare research and their manufacturing expansion.
Horizon Databook provides a detailed overview of country-level data and insights on the UK single-use bioprocessing probes and sensors market , including forecasts for subscribers. This country databook contains high-level insights into UK single-use bioprocessing probes and sensors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account